CN104958355A - Medicine containing incised notopterygium - Google Patents

Medicine containing incised notopterygium Download PDF

Info

Publication number
CN104958355A
CN104958355A CN201510460235.3A CN201510460235A CN104958355A CN 104958355 A CN104958355 A CN 104958355A CN 201510460235 A CN201510460235 A CN 201510460235A CN 104958355 A CN104958355 A CN 104958355A
Authority
CN
China
Prior art keywords
parts
alopecia
medicine
incised notopterygium
medicine containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510460235.3A
Other languages
Chinese (zh)
Inventor
不公告发明人
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510460235.3A priority Critical patent/CN104958355A/en
Publication of CN104958355A publication Critical patent/CN104958355A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medicine containing incised notopterygium. The medicine comprises the following raw materials in parts by mass: 10-20 parts of incised notopterygium, 30-40 parts of radix astragali and 40-60 parts of suberect spatholobus stem. The medicine has obvious treatment effects on alopecia areata and does not have obvious toxic or side effect.

Description

Medicine containing Rhizoma Et Radix Notopterygii
Technical field
The invention belongs to biomedicine field, be specifically related to a kind of medicine containing Rhizoma Et Radix Notopterygii.
Background technology
Alopecia is clinical common trichopathy, though do not belong to serious disease, produces larger impact to the spirit of people, psychology.Along with growth in the living standard, people are day by day urgent to the requirement of cosmetology, and modern medicine and traditional medicine also more and more pay attention to the research to alopecia.
Alopecia refers to the phenomenon of alopecia.The hair normally come off is all the hair being in catagen and resting stage, is constantly in dynamic equilibrium, therefore can maintains the hair of normal quantity owing to entering catagen with the hair newly entering trophophase.Pathologic alopecia refers to abnormal or excessive the coming off of hair, and clinical common pathologic alopecia comprises the types such as alopecia areata, seborrheic alopecia, alopecia due to chemotherapy, growing period alopecia, telogen effluvim, wherein with alopecia areata and seborrheic alopecia sickness rate the highest.
Alopecia areata is commonly called as " alopecia areata ", and being meant to wake up from a sleep finds alopecia in blocks unconsciously.This sick normal generation suddenly, often gets a haircut in combing one's hair or others inadvertently finds.Alopecia areata shows as circle or oval alopecia district more, and number is the amount doesn't matter, and size is also different, little of Semen Viciae fabae, and large can like egg size.Alopecia portion skin is normal, no conscious sympton, and some alopecias gradually can grow new sending out without treatment behind 2 ~ 3 months or longer time.The hair of new length is more soft, and color is more shallow, later slowly thicker hardening, and color and luster is deepened until completely normal.Also have some patients length of side limit to take off and go through several years, what have has fully recovered after treatment, but recurs again soon, so repeatedly reaches for more than ten years.
Alopecia areata is the result of multifactor functioning, has both comprised the change that heredity, immunomodulating also relate to the aspects such as endocrine, cause of disease more complicated, and has studied clear not yet completely.Be applied to the object that clinical medicine and method also do not realize effective treatment alopecia areata at present, and various degrees side effect, the easy shortcoming such as recurrence after drug withdrawal.Because Chinese herb prevention alopecia has special effect, the advantage that integrally-regulated, side effect is little, people start sight to transfer in the research of Chinese medicine.Chinese medicine has the history of more than one thousand years in hair growth, modern study also finds that much Chinese medicine has trichogenous effect, such as conventional during hair growth Radix Polygoni Multiflori is not only rich in the necessary trace element of natural on-off cycles of hair growth such as ferrum, zinc, manganese, also containing a large amount of active component, new life and the growth of cell can be promoted.Play the advantage of motherland's Chinese medicine, will have broad prospects in treatment and prevention alopecia areata.
Summary of the invention
Comprehensive state of the art and Problems existing, the object of the present invention is to provide a kind of medicine containing Rhizoma Et Radix Notopterygii, the present invention is pure Chinese medicinal preparation, without any side effects, treatment alopecia areata successful.
For achieving the above object, the present invention is made up of the raw material of following masses ratio: Rhizoma Et Radix Notopterygii 10-20 part, Radix Astragali 30-40 part, Caulis Spatholobi 40-60 part.Dosage form of the present invention is tincture, and doubly 75% soak with ethanol is stand-by after one week can to select 5-10, puts on the skin outward.
Detailed description of the invention
Embodiment 1. the present invention be made up of the raw material of following masses ratio: Rhizoma Et Radix Notopterygii 10 parts, the Radix Astragali 40 parts, Caulis Spatholobi 60 parts.
Embodiment 2. the present invention be made up of the raw material of following masses ratio: Rhizoma Et Radix Notopterygii 20 parts, the Radix Astragali 20 parts, Caulis Spatholobi 40 parts.
Embodiment 3. the present invention be made up of the raw material of following masses ratio: Rhizoma Et Radix Notopterygii 15 parts, the Radix Astragali 30 parts, Caulis Spatholobi 50 parts.

Claims (2)

1. the medicine containing Rhizoma Et Radix Notopterygii, is made up of the raw material of following masses ratio: Rhizoma Et Radix Notopterygii 10-20 part, Radix Astragali 30-40 part, Caulis Spatholobi 40-60 part.
2. the medicine according to claim 1 containing Rhizoma Et Radix Notopterygii, is characterized in that: described form of administration is tincture.
CN201510460235.3A 2015-07-31 2015-07-31 Medicine containing incised notopterygium Pending CN104958355A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510460235.3A CN104958355A (en) 2015-07-31 2015-07-31 Medicine containing incised notopterygium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510460235.3A CN104958355A (en) 2015-07-31 2015-07-31 Medicine containing incised notopterygium

Publications (1)

Publication Number Publication Date
CN104958355A true CN104958355A (en) 2015-10-07

Family

ID=54212560

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510460235.3A Pending CN104958355A (en) 2015-07-31 2015-07-31 Medicine containing incised notopterygium

Country Status (1)

Country Link
CN (1) CN104958355A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120441A (en) * 1994-10-11 1996-04-17 刘海套 Trichogen pill

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120441A (en) * 1994-10-11 1996-04-17 刘海套 Trichogen pill

Similar Documents

Publication Publication Date Title
CN105012910A (en) Tincture for treating alopecia seborrhoeica
CN104958740A (en) Traditional Chinese medicine composition containing fresh ginger
CN110507590A (en) A kind of hair care Essence
CN104958739A (en) Traditional Chinese medicine composition
CN104958741A (en) Compound preparation containing Chinese arborvitae twig
CN102641353A (en) Hair growth conditioner rich in plant flavonoids
CN104958354A (en) Tincture for treating alopecia areata
CN107334894A (en) A kind of composition for treating alopecia seborrheica
CN104958369A (en) Medicine for treating seborrheic alopecia
CN104958370A (en) Tincture for treating alopecia
CN104958355A (en) Medicine containing incised notopterygium
CN104958480A (en) Medicine for promoting hair growth in position of alopecia areata
CN104983973A (en) Traditional Chinese medicinal preparation
CN104958353A (en) Medicine preparation
CN104983781A (en) Tincture
CN104958350A (en) Compound preparation containing incised notopterygium
CN104983780A (en) Tincture for treating alopecia areata
CN104958479A (en) Traditional Chinese medicine preparation
CN104958482A (en) Compound traditional chinese medicine preparation
CN104958344A (en) Medicine for treating alopecia areata
CN104983765A (en) Compound preparation containing radix sileris
CN104983969A (en) Drug for promoting hair of alopecia areata part to grow
CN105362992A (en) Medicine for treating alopecia
CN104958343A (en) Medicine for treating alopecia areata
CN105381432A (en) Tincture for treating alopecia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151007